PE Ratio
17.58
₹42.75 2.90 (7.28%)
As on September 4, 2026
-39.75%
1 Y CAGR
73
CR
Market Cap
Company profile
Zenith Drugs Ltd. engages in the manufacture and trade of medicines. It offers a wide range of formulations in various forms such as ORS powder, liquid orals, ointments, liquid externals, and capsules. The company was founded by Shri Ramniklal T. Soni and Mr. Mukesh Jain on November 15, 2000 and is headquartered in Indore, India.
Price Chart
Fundamentals - Company Valuation
PB Ratio
0.059
Dividend Yield
0.74%
Sector PE
47.63
Sector ROE
11.70%
Sector Dividend Yield
0.46%
Financials
LIVE DATA FEED
Total Revenue (YTD)
₹1.7KCAGR 5-Year
+16.91%Peers & Comparison
SUNPHARMA
Sun Pharmaceutical Industries Ltd
Market cap: ₹4,41,477.63 Cr
DIVISLAB
Divi's Laboratories Ltd
Market cap: ₹2,41,576.41 Cr
TORNTPHARM
Torrent Pharmaceuticals Ltd
Market cap: ₹1,82,576.57 Cr
Missed the last rally? Don’t miss the next
Looking for AI-researched technical positive stocks?
Our AI-powered Analytical Portal finds the strongest technical positive stocks with actionable Buy & Sell opportunities.
Corporate Actions
Still Thinking? Not sure which stocks are right for you?
We help investors understand what to buy, when to buy, and why it makes sense for them.
customersupport@jarvisinvest.com
New Customers (Enquiry): +91 7208809638
Mon - Sat | 10:00 AM - 07:00 PM (Sunday Closed)
